PURA CBD BEVERAGE SALES AND SHARE PRICE READY TO SOAR
November 13, 2019 -- InvestorsHub NewsWire -- via Seeking Alpha --
Cowen, one of the leading experts in markets and sales projections for Cannabis, and CBD forecasts CBD can generate sales of $16 billion by 2025 and that CBD infused water will account for the biggest CBD beverage sales of about $1 billion in 2020. The projected growth rate of CBD sales is so strong that giants like Coke,Pepsi and Unilever are all seriously eyeing CBD infused beverages.
Being a small CBD Beverage company like Puration, (OTC: PURA) has the enormous advantage of being able to move fast and first, and that is precisely what this nimble little company has done. In the time that corporate giants are still doing their research followed by long-winded reports and distant board meetings, PURA has already launched EVERx CBD Infused Sports Waters.
EVERx has since become the leading CBD infused beverage in the sports nutrition market place. The company's sales grew 600% in the first year after the launch of EVERx. Kiwi Strawberry and Lemon Lime flavors are now available in addition the Original EVERx CBD Infused Sports Water. EVERx has more than twice the CBD of most CBD infused waters on the market. A proprietary technology enables EVERx to suspend more CBD than its competitors and still have a crystal-clear appearance and a refreshing taste. The company has recently initiated a package redesign after extensive market testing of a new logo design. Consumer demand for CBD infused beverages is growing and Puration is likewise receiving inquiries from a broader array of retail outlets. The package redesign is the first step of a comprehensive marketing plan to dramatically increase EVERx sales over the next 24 months.
Puration sales went from an impressive $1 million in 2018, to being on track to achieve $4 million in 2019, to a projected $8 million in 2020 which is about here in just months.
Puration has a very compelling story that cannot escape promotion because the growth is so dramatic. One look at the bullets and the links above tells the story of a very focused company with a solid plan to capture a substantial portion of an remarkably fast growing CBD beverage market.
Goldman Small Cap Research targets PURA shares at $.35 which is about 7 times today’s price.
With the powerful growth forecast for CBD beverages combined with Puration’s early head start and already fast-climbing sales, PURA shares appear to be highly undervalued and a strong buy.
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Emerging MicroCaps or BioResearchAlert or its principals may have been compensated for its services in the form of cash-based compensation. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as ''expects,'' ''will,'' ''anticipates,'' and ''estimates''; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements.
Disclosure: I/we have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.
SOURCE: Seeking Alpha